Pennsylvania Advanced Practice Nurse CE Package
This convenient 30-hour package of CE courses includes 24 contact hours of pharmacology to help you meet the requirements for Pennsylvania advanced practice nursing license renewal. Additionally, you'll find a board-approved 2-hour course on child abuse recognition and reporting, a course related to pain management and opioid use, and an 8-hour course that will meet the Drug Enforcement Administration (DEA)’s new training requirement under the Medication Access and Training Expansion (MATE) Act.
Included Courses
Courses included in this package. Click on a course to learn more.
- Pennsylvania Mandatory Child Abuse Recognition and Reporting (Renewal Licensure) 2Course release date: 1/20/2021
About the Course:
This course fulfills the Pennsylvania Healthcare Professionals 2-year licensure renewal continuing education requirement for 2 contact hours of Child Abuse Recognition and Reporting. The course provides the details of the identification, assessment, and reporting of child abuse and reviews Pennsylvania's state laws regarding child abuse and neglect. - Pain Management and Opioid Use for Pennsylvania Advanced Practice Nurses 4 4Course release date: 10/12/2022
About the Course
In accordance with Section 9.1(a) of ABC-MAP, this course meets the requirements for advanced practice nurse prescribers. This course includes two hours of pain management and identification of addiction and two contact hours in the practices of prescribing and dispensing opioids. - Chronic Obstructive Pulmonary Disease: New Clinical Challenges 2
Course release date: 10/09/2023
About the Course
This course will provide health professionals with comprehensive information regarding pathophysiology, the etiologies, the diagnosis of, and clinical management of patients with chronic obstructive pulmonary disease (COPD). This course will also address the benefits of a multidisciplinary approach regarding the care of patients with COPD. It will stress how best the clinical can work as a team to optimize outcomes and ensure the best treatment regime for the COPD patient.
- Clinical Management of Substance Use Disorders 5 5
Course release date: 7/10/2023
About the Course
Substance use and abuse cost society more than $740 billion annually in workplace productivity, healthcare, and crime-related expenses (NIDA, 2020). Substance use disorders are complex phenomena affecting individuals' and families’ lives. This course reviews common substance use disorders, including alcohol, anxiolytics, stimulants, hallucinogens, and tobacco/vaping. The course also examines federal and state-controlled substance regulations and the prescribing practices for controlled substances. The focus is on clinical and safety considerations by nurse practitioners when prescribing non-cancer-related opioid medications for acute/chronic pain. - Identifying Common Rashes in Urgent Care: A Case Study Approach for APRNs 4 2
Course release date: 7/10/2023
Family nurse practitioners (FNPs) and emergency nurse practitioners (ENPs) care for patients with many ailments in the emergency department (ED). Some patients with low acute conditions make many ED visits, which contributes to service overcrowding and a large number of visits classified by providers as inappropriate (Pacheco et al., 2019). Most emergency departments have an area for minor injuries and acute exacerbations of chronic conditions. Fast-track and urgent care centers are typically staffed by nurse practitioners (NPs) and physician associates (PAs). Some primary care offices provide urgent care visits as walk-ins. Dermatological complaints constitute 5%–8% of all emergency department (ED) visits (Kilic et al., 2019). In one study, more than half (58.9%) of dermatologic ED visits were due to cellulitis plus abscess (Nadkarni et al., 2016). Knowing common dermatologic presentations may help providers educate patients about the proper care for skin conditions and potentially impact ED utilization. The purpose of this course is to characterize the most common dermatologic diagnoses in the urgent care setting. The goal is to build provider confidence in assessing, diagnosing, and treating rashes in the urgent care setting.?
- Management of Atrial Fibrillation for APRNs 2 2Course release date: 4/5/2022
About the Course
Atrial fibrillation is a common healthcare problem. This course reviews the concepts of cardiac output, risk factors for atrial fibrillation (AF), classifications of AF, the pearls of obtaining a history and physical of a patient with AF, diagnostic testing, and the overall implications for pharmacologic management. APRN prescribing considerations and evidence-based practice guidelines are included in this course.
- Pharmacological Management: Type 1 Diabetes in Children, 2nd Edition 3 3Course release date: 12/21/2022
About the Course
The purpose of this course is to review diagnostic criteria, insulin pharmacokinetics and dosing strategies, hypoglycemia management, and psychosocial considerations in the pediatric type 1 diabetes mellitus patient. Diabetes is one of the most common chronic diseases in pediatric patients, and newly diagnosed cases are on the rise. Management of type 1 diabetes mellitus requires specialized knowledge and individualized treatment plans. All pediatric healthcare professionals should be equipped to help patients achieve glycemic control through optimized therapy and continual education. - Prescribing Controlled Substances Safely: A DEA Requirement 8 8
Course release date: 5/1/2023
About the Course
Nurse Practitioners (NPs), Physician Assistants (PAs), Pharmacists, and Dentists care for patients with disorders in many healthcare settings. Individuals may seek care for an acute illness or worsening of a chronic condition. Often, pain is the leading reason for seeking medical care. Appropriate prescribing practices are critical for all medications, but controlled substances require special attention. The Drug Enforcement Agency (DEA), the Food and Drug Administration (FDA), and the U.S. Department of Health and Human Services (HHS) all have a role in controlled medication schedules. Prescribers must understand federal and state requirements for all controlled substances. This course will provide a general review of federal and state-controlled substance regulations and the prescribing practices for controlled substances. Additionally, substance use disorders are complex phenomena affecting many lives. This course also reviews common substance use disorders, including alcohol, anxiolytics, stimulants, hallucinogens, and tobacco/vaping. However, the focus is on clinical safety considerations when prescribing non-cancer-related opioid medications for acute/chronic pain in adults.